Feb 06, 2023 / NTS GMT
Presentation
Feb 06, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Chairman of the Board
* Minoru Kikuoka
Astellas Pharma Inc. - CFO & Senior Managing Executive Officer
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, Chief Strategy Officer & Representative Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa
Astellas Pharma Inc
(STU:YPH)
€
11.4
+0.10 (+0.88%)
Market Cap: 20.87 Bil
Enterprise Value: 22.37 Bil
PE Ratio: 13.32
PB Ratio: 2.12
GF Score: 83/100 Q3 2023 Astellas Pharma Inc Earnings Presentation Transcript
Feb 06, 2023 / NTS GMT
Release Date Price:
€13.24
(-1.05%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot